{"transactions":[{"id":4635261,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21172,"kind":"person","name":"Plott Ronald Todd","position":1,"cik":"0001768337","reported_name":"Plott Ronald Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-30T20:01:04.000Z","date":"2026-09-29","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.04,"value":5200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":42000,"source":{"system":"sec-edgar","filing":"0001683168-26-007499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007499/ownership.xml","form_type":"4"}},{"id":4635260,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21172,"kind":"person","name":"Plott Ronald Todd","position":1,"cik":"0001768337","reported_name":"Plott Ronald Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-30T20:01:04.000Z","date":"2026-09-28","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.03,"value":5150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":37000,"source":{"system":"sec-edgar","filing":"0001683168-26-007499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007499/ownership.xml","form_type":"4"}},{"id":4628145,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67434,"kind":"person","name":"Carson Lisa Cabott","position":1,"cik":"0002073513","reported_name":"Carson Lisa Cabott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-29T20:01:07.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":189112,"source":{"system":"sec-edgar","filing":"0001683168-26-007481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073513/000168316826007481/ownership.xml","form_type":"4"}},{"id":4628146,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-29T20:01:05.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":764871,"source":{"system":"sec-edgar","filing":"0001683168-26-007483","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007483/ownership.xml","form_type":"4"}},{"id":4628147,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21172,"kind":"person","name":"Plott Ronald Todd","position":1,"cik":"0001768337","reported_name":"Plott Ronald Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-29T20:01:04.000Z","date":"2026-09-28","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001683168-26-007482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1768337/000168316826007482/ownership.xml","form_type":"4"}},{"id":4626866,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-25T20:01:23.000Z","date":"2026-09-24","kind":"purchase","planned":false,"acquired":true,"shares":6500,"price":1.0127,"value":6582.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":64151,"source":{"system":"sec-edgar","filing":"0001683168-26-007432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007432/ownership.xml","form_type":"4"}},{"id":4625347,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-23T20:01:23.000Z","date":"2026-09-22","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.0289,"value":2057.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":364871,"source":{"system":"sec-edgar","filing":"0001683168-26-007321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007321/ownership.xml","form_type":"4"}},{"id":4619122,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-16T20:01:10.000Z","date":"2026-09-15","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":1.03,"value":12360.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":57651,"source":{"system":"sec-edgar","filing":"0001683168-26-007192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007192/ownership.xml","form_type":"4"}},{"id":4617770,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67434,"kind":"person","name":"Carson Lisa Cabott","position":1,"cik":"0002073513","reported_name":"Carson Lisa Cabott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-15T20:00:31.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":12888,"price":1.03,"value":13274.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":81112,"source":{"system":"sec-edgar","filing":"0001683168-26-007158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073513/000168316826007158/ownership.xml","form_type":"4"}},{"id":4617771,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-09-15T20:00:29.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":68550,"price":1.03,"value":70606.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":362871,"source":{"system":"sec-edgar","filing":"0001683168-26-007159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826007159/ownership.xml","form_type":"4"}},{"id":679734,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21172,"kind":"person","name":"Plott Ronald Todd","position":1,"cik":"0001768337","reported_name":"Plott Ronald Todd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-08-20T12:30:03.000Z","date":"2026-08-19","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.14,"value":17100.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001683168-26-006620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826006620/ownership.xml","form_type":"4"}},{"id":681141,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-08-19T20:01:10.000Z","date":"2026-08-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.06,"value":10600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":431421,"source":{"system":"sec-edgar","filing":"0001683168-26-006592","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826006592/ownership.xml","form_type":"4"}},{"id":723813,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-06-29T20:02:13.000Z","date":"2026-06-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.99,"value":9900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":421421,"source":{"system":"sec-edgar","filing":"0001683168-26-005164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826005164/ownership.xml","form_type":"4"}},{"id":915798,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T13:00:21.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":32655,"source":{"system":"sec-edgar","filing":"0001683168-26-000811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826000811/ownership.xml","form_type":"4"}},{"id":915800,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67392,"kind":"person","name":"Deming David H","position":1,"cik":"0001641063","reported_name":"Deming David H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T12:59:20.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":23800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":37800,"source":{"system":"sec-edgar","filing":"0001683168-26-000809","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316826000809/ownership.xml","form_type":"4"}},{"id":915851,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T12:56:15.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":411421,"source":{"system":"sec-edgar","filing":"0001683168-26-000803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826000803/ownership.xml","form_type":"4"}},{"id":915825,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T08:01:09.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":35155,"source":{"system":"sec-edgar","filing":"0001683168-26-000813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316826000813/ownership.xml","form_type":"4"}},{"id":916289,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67434,"kind":"person","name":"Carson Lisa Cabott","position":1,"cik":"0002073513","reported_name":"Carson Lisa Cabott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T07:58:27.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":94000,"source":{"system":"sec-edgar","filing":"0001683168-26-000807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073513/000168316826000807/ownership.xml","form_type":"4"}},{"id":915849,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T07:57:36.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":45651,"source":{"system":"sec-edgar","filing":"0001683168-26-000805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313325/000168316826000805/ownership.xml","form_type":"4"}},{"id":954997,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2026-01-02T21:05:06.000Z","date":"2025-12-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.03,"value":5150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":291421,"source":{"system":"sec-edgar","filing":"0001683168-26-000013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316826000013/ownership.xml","form_type":"4"}},{"id":958032,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-12-29T13:10:21.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.02,"value":5100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":286421,"source":{"system":"sec-edgar","filing":"0001683168-25-009349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825009349/ownership.xml","form_type":"4"}},{"id":989772,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-11-24T17:54:10.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.14,"value":5700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":281421,"source":{"system":"sec-edgar","filing":"0001683168-25-008639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825008639/ownership.xml","form_type":"4"}},{"id":993580,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-11-19T17:47:40.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.27,"value":6350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":276421,"source":{"system":"sec-edgar","filing":"0001683168-25-008537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825008537/ownership.xml","form_type":"4"}},{"id":1040146,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T20:02:03.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":23100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"shares","element":"transactionShares","label":"F4","text":"This amended Form 4 corrects the number of stock options reported in the original Form 4 filed on September 15, 2025. The original filing incorrectly stated that 23,000 restricted stock units were granted. The correct number of restricted stock units granted was 23,100. Securities beneficially owned changed from 38,666 to 38,766."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This amended Form 4 corrects the number of stock options reported in the original Form 4 filed on September 15, 2025. The original filing incorrectly stated that 23,000 restricted stock units were granted. The correct number of restricted stock units granted was 23,100. Securities beneficially owned changed from 38,666 to 38,766."}],"balance_after":38766,"source":{"system":"sec-edgar","filing":"0001683168-25-006986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006986/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-15"}},{"id":1040145,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67392,"kind":"person","name":"Deming David H","position":1,"cik":"0001641063","reported_name":"Deming David H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:30:15.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001683168-25-006961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006961/ownership.xml","form_type":"4"}},{"id":1040147,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:29:41.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":14700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":16055,"source":{"system":"sec-edgar","filing":"0001683168-25-006958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006958/ownership.xml","form_type":"4"}},{"id":1040144,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:29:12.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":38666,"source":{"system":"sec-edgar","filing":"0001683168-25-006957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006957/ownership.xml","form_type":"4"}},{"id":1040209,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:28:05.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":271421,"source":{"system":"sec-edgar","filing":"0001683168-25-006954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825006954/ownership.xml","form_type":"4"}},{"id":1040208,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres. & CEO"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T12:28:05.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4111,"price":2.32,"value":9537.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."}],"balance_after":21421,"source":{"system":"sec-edgar","filing":"0001683168-25-006954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316825006954/ownership.xml","form_type":"4"}},{"id":1040191,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T08:29:58.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":18555,"source":{"system":"sec-edgar","filing":"0001683168-25-006959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316825006959/ownership.xml","form_type":"4"}},{"id":1040719,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67434,"kind":"person","name":"Carson Lisa Cabott","position":1,"cik":"0002073513","reported_name":"Carson Lisa Cabott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and Administration"}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T08:28:50.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001683168-25-006956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073513/000168316825006956/ownership.xml","form_type":"4"}},{"id":1040207,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T08:28:35.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":18800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":27151,"source":{"system":"sec-edgar","filing":"0001683168-25-006955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313325/000168316825006955/ownership.xml","form_type":"4"}},{"id":1114717,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-11T21:00:01.000Z","date":"2025-06-10","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.42,"value":4840.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":27149,"source":{"system":"sec-edgar","filing":"0001062993-25-011424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325011424/form4.xml","form_type":"4"}},{"id":1114640,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2025-06-11T20:59:45.000Z","date":"2025-06-10","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.4199,"value":6049.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":15666,"source":{"system":"sec-edgar","filing":"0001062993-25-011423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000106299325011423/form4.xml","form_type":"4"}},{"id":1116110,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-10T20:43:57.000Z","date":"2025-06-09","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":2.75,"value":4125.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":25149,"source":{"system":"sec-edgar","filing":"0001062993-25-011326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325011326/form4.xml","form_type":"4"}},{"id":1134939,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-23T13:04:08.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":1200,"price":1.7799,"value":2135.88,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":23649,"source":{"system":"sec-edgar","filing":"0001062993-25-010155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325010155/form4.xml","form_type":"4"}},{"id":1134938,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-23T13:04:08.000Z","date":"2025-05-21","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":1.77,"value":5310.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":22449,"source":{"system":"sec-edgar","filing":"0001062993-25-010155","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000106299325010155/form4.xml","form_type":"4"}},{"id":1138722,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2025-05-21T20:13:14.000Z","date":"2025-05-20","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.82,"value":4550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $1.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":13166,"source":{"system":"sec-edgar","filing":"0001062993-25-009985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000106299325009985/form4.xml","form_type":"4"}},{"id":1407443,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-13T18:59:52.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001683168-24-006375","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824006375/ownership.xml","form_type":"4"}},{"id":1407498,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, Pres & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-13T18:59:23.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":17832,"source":{"system":"sec-edgar","filing":"0001683168-24-006373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824006373/ownership.xml","form_type":"4"}},{"id":1407900,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":87560,"kind":"person","name":"Infarinato Robert M.","position":1,"cik":"0002032518","reported_name":"Infarinato Robert M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, CFO"}}],"security":"Common Stock, $0.0001 Par Value","published_at":"2024-09-13T15:00:20.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001683168-24-006377","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032518/000168316824006377/ownership.xml","form_type":"4"}},{"id":1408403,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2024-09-12T20:11:23.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001683168-24-006334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824006334/ownership.xml","form_type":"4"}},{"id":1408414,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-12T16:11:58.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001683168-24-006336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316824006336/ownership.xml","form_type":"4"}},{"id":1408461,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-12T16:10:54.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001683168-24-006332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313325/000168316824006332/ownership.xml","form_type":"4"}},{"id":1432740,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":87560,"kind":"person","name":"Infarinato Robert M.","position":1,"cik":"0002032518","reported_name":"Infarinato Robert M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Financial Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-08-15T16:14:18.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001683168-24-005773","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032518/000168316824005773/ownership.xml","form_type":"4"}},{"id":1483161,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-06-11T21:00:11.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.74,"value":740.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20990,"source":{"system":"sec-edgar","filing":"0001683168-24-004126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824004126/ownership.xml","form_type":"4"}},{"id":1484614,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-06-10T21:00:16.000Z","date":"2024-06-06","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.75,"value":750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":19990,"source":{"system":"sec-edgar","filing":"0001683168-24-004089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824004089/ownership.xml","form_type":"4"}},{"id":1594401,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-03-06T00:00:05.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":335,"price":0.958,"value":320.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":10643,"source":{"system":"sec-edgar","filing":"0001683168-24-001324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824001324/ownership.xml","form_type":"4"}},{"id":1615137,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-27T21:42:27.000Z","date":"2024-02-26","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.91,"value":2275.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":18990,"source":{"system":"sec-edgar","filing":"0001683168-24-001216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824001216/ownership.xml","form_type":"4"}},{"id":1624993,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-23T00:00:12.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1804,"price":0.76,"value":1371.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":16490,"source":{"system":"sec-edgar","filing":"0001683168-24-001134","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000168316824001134/ownership.xml","form_type":"4"}},{"id":1632737,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-21T00:03:51.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":523,"price":0.66,"value":345.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":10978,"source":{"system":"sec-edgar","filing":"0001683168-24-001086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824001086/ownership.xml","form_type":"4"}},{"id":1632736,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-21T00:03:51.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":658,"price":0.65,"value":427.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":11501,"source":{"system":"sec-edgar","filing":"0001683168-24-001086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824001086/ownership.xml","form_type":"4"}},{"id":1766815,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-10-03T23:00:14.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":917,"price":1.51,"value":1384.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":18294,"source":{"system":"sec-edgar","filing":"0001209191-23-051706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123051706/doc4.xml","form_type":"4"}},{"id":1835452,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-07-05T22:00:29.000Z","date":"2023-07-01","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.84,"value":2840.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":19211,"source":{"system":"sec-edgar","filing":"0001209191-23-041254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123041254/doc4.xml","form_type":"4"}},{"id":1835451,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-07-05T22:00:29.000Z","date":"2023-06-30","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.88,"value":2880.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":18211,"source":{"system":"sec-edgar","filing":"0001209191-23-041254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123041254/doc4.xml","form_type":"4"}},{"id":1853944,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-06-15T21:00:13.000Z","date":"2023-06-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.1,"value":6200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-037408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123037408/doc4.xml","form_type":"4"}},{"id":1971912,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-03-03T23:00:26.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":335,"price":5.49,"value":1839.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":12159,"source":{"system":"sec-edgar","filing":"0001209191-23-015880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123015880/doc4.xml","form_type":"4"}},{"id":1998893,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:25:15.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":3197,"source":{"system":"sec-edgar","filing":"0001209191-23-011937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123011937/doc4.xml","form_type":"4"}},{"id":1998892,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:20:15.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-23-011932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123011932/doc4.xml","form_type":"4"}},{"id":1998891,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:05:19.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":12494,"source":{"system":"sec-edgar","filing":"0001209191-23-011911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123011911/doc4.xml","form_type":"4"}},{"id":1999110,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:00:10.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in two equal annual installments commencing on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":17211,"source":{"system":"sec-edgar","filing":"0001209191-23-011909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919123011909/doc4.xml","form_type":"4"}},{"id":1999046,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-22T19:30:12.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":3197,"source":{"system":"sec-edgar","filing":"0001209191-23-011942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919123011942/doc4.xml","form_type":"4"}},{"id":1999261,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-22T19:15:10.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":4235,"source":{"system":"sec-edgar","filing":"0001209191-23-011926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919123011926/doc4.xml","form_type":"4"}},{"id":1999109,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-22T19:10:13.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":3167,"source":{"system":"sec-edgar","filing":"0001209191-23-011920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313325/000120919123011920/doc4.xml","form_type":"4"}},{"id":2006627,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-17T23:30:20.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":657,"price":5.2,"value":3416.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":7994,"source":{"system":"sec-edgar","filing":"0001209191-23-010876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123010876/doc4.xml","form_type":"4"}},{"id":2084889,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-15T22:00:30.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":2000,"price":0.39,"value":780.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":74541,"source":{"system":"sec-edgar","filing":"0001209191-22-061471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122061471/doc4.xml","form_type":"4"}},{"id":2092051,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-08T21:30:23.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":2000,"price":0.39,"value":780.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":72541,"source":{"system":"sec-edgar","filing":"0001209191-22-060358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122060358/doc4.xml","form_type":"4"}},{"id":2094256,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-06T21:30:18.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":2000,"price":0.43,"value":860.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":70541,"source":{"system":"sec-edgar","filing":"0001209191-22-060009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122060009/doc4.xml","form_type":"4"}},{"id":2095615,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-12-05T21:30:23.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":5000,"price":0.4082,"value":2041.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.4075 to $0.4089. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-22-059702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122059702/doc4.xml","form_type":"4"}},{"id":2102273,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-11-29T21:30:15.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":215,"price":0.4,"value":86.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":68541,"source":{"system":"sec-edgar","filing":"0001209191-22-058942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122058942/doc4.xml","form_type":"4"}},{"id":2102272,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-11-29T21:30:15.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":2500,"price":0.42,"value":1050.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":68326,"source":{"system":"sec-edgar","filing":"0001209191-22-058942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122058942/doc4.xml","form_type":"4"}},{"id":2103176,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-11-28T21:30:18.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":2000,"price":0.4099,"value":819.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-22-058862","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122058862/doc4.xml","form_type":"4"}},{"id":2114304,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chairman"}}],"security":"Series D Preferred Stock, $0.0001 par value","published_at":"2022-11-16T22:06:34.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":1,"price":1750,"value":1750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The outstanding share of Series D Preferred Stock shall be redeemed in whole, but not in part, at any time: (i) if such redemption is approved by the Board of Directors in its sole discretion or (ii) automatically and effective upon the approval of an amendment to the Certificate of Incorporation to implement a reverse stock split. Upon redemption, the share of Series D Preferred Stock will receive consideration of $1,750.00 in cash."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001209191-22-057333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122057333/doc4.xml","form_type":"4"}},{"id":2147054,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-10-04T00:01:10.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":65826,"source":{"system":"sec-edgar","filing":"0001209191-22-051984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122051984/doc4.xml","form_type":"4"}},{"id":2151167,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67398,"kind":"person","name":"BRADFORD PATRICIA A","position":1,"cik":"0001313325","reported_name":"BRADFORD PATRICIA A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-09-26T19:00:13.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-22-051302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313325/000120919122051302/doc4.xml","form_type":"4"}},{"id":2353000,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-03-04T00:13:32.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4011,"price":0.821,"value":3293.031,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":103815,"source":{"system":"sec-edgar","filing":"0001209191-22-015894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122015894/doc4.xml","form_type":"4"}},{"id":2352999,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-03-04T00:12:51.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":8954,"price":0.821,"value":7351.234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":212327,"source":{"system":"sec-edgar","filing":"0001209191-22-015893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122015893/doc4.xml","form_type":"4"}},{"id":2391341,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:10:37.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":107826,"source":{"system":"sec-edgar","filing":"0001209191-22-010402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010402/doc4.xml","form_type":"4"}},{"id":2391334,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:08:38.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20364,"source":{"system":"sec-edgar","filing":"0001209191-22-010396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010396/doc4.xml","form_type":"4"}},{"id":2391332,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:06:56.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001209191-22-010391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010391/doc4.xml","form_type":"4"}},{"id":2391333,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":130336,"kind":"person","name":"Dorman H. Paul","position":1,"cik":"0001575028","reported_name":"Dorman H. Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:05:05.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20370,"source":{"system":"sec-edgar","filing":"0001209191-22-010388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010388/doc4.xml","form_type":"4"}},{"id":2391331,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:03:20.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":221281,"source":{"system":"sec-edgar","filing":"0001209191-22-010384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010384/doc4.xml","form_type":"4"}},{"id":2391452,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T00:59:51.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":25826,"source":{"system":"sec-edgar","filing":"0001209191-22-010372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919122010372/doc4.xml","form_type":"4"}},{"id":2391369,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-16T20:12:03.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20366,"source":{"system":"sec-edgar","filing":"0001209191-22-010405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919122010405/doc4.xml","form_type":"4"}},{"id":2391529,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-16T20:01:45.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":32822,"source":{"system":"sec-edgar","filing":"0001209191-22-010377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919122010377/doc4.xml","form_type":"4"}},{"id":2599393,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-08-17T13:11:24.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":6000,"price":1.63,"value":9780.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":95281,"source":{"system":"sec-edgar","filing":"0001209191-21-051759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121051759/doc4.xml","form_type":"4"}},{"id":2805413,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-05T12:05:07.000Z","date":"2021-03-04","kind":"purchase","acquired":true,"shares":1953,"price":2.56,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":89281,"source":{"system":"sec-edgar","filing":"0001209191-21-018054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121018054/doc4.xml","form_type":"4"}},{"id":2811654,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":130336,"kind":"person","name":"Dorman H. Paul","position":1,"cik":"0001575028","reported_name":"Dorman H. Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:30.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the\nissuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":10370,"source":{"system":"sec-edgar","filing":"0001209191-21-017575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017575/doc4.xml","form_type":"4"}},{"id":2811650,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67391,"kind":"person","name":"Freeman Jonathan E","position":1,"cik":"0001708133","reported_name":"Freeman Jonathan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:25.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":10364,"source":{"system":"sec-edgar","filing":"0001209191-21-017574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017574/doc4.xml","form_type":"4"}},{"id":2812165,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:18.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":15826,"source":{"system":"sec-edgar","filing":"0001209191-21-017570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919121017570/doc4.xml","form_type":"4"}},{"id":2811649,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:17.000Z","date":"2021-03-03","kind":"purchase","acquired":true,"shares":682,"price":3.15,"value":2148.3,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-21-017572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017572/doc4.xml","form_type":"4"}},{"id":2811648,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":75364,"kind":"person","name":"Ferrara Robert L","position":1,"cik":"0001792987","reported_name":"Ferrara Robert L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:05:17.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":12318,"source":{"system":"sec-edgar","filing":"0001209191-21-017572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017572/doc4.xml","form_type":"4"}},{"id":2811647,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:00:14.000Z","date":"2021-03-03","kind":"purchase","acquired":true,"shares":2500,"price":3.03,"value":7575.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":87328,"source":{"system":"sec-edgar","filing":"0001209191-21-017569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017569/doc4.xml","form_type":"4"}},{"id":2811646,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:00:14.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":68450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":84828,"source":{"system":"sec-edgar","filing":"0001209191-21-017569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017569/doc4.xml","form_type":"4"}},{"id":2811645,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:00:12.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":34600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":39826,"source":{"system":"sec-edgar","filing":"0001209191-21-017568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017568/doc4.xml","form_type":"4"}},{"id":2812429,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-03T21:05:31.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a\nratio of 1-for-55."}],"balance_after":22822,"source":{"system":"sec-edgar","filing":"0001209191-21-017573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919121017573/doc4.xml","form_type":"4"}},{"id":2811889,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-03T21:05:22.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a\nratio of 1-for-55."}],"balance_after":10366,"source":{"system":"sec-edgar","filing":"0001209191-21-017571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919121017571/doc4.xml","form_type":"4"}},{"id":3051920,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2020-08-19T21:00:08.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":2000,"price":2.5,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":16377,"source":{"system":"sec-edgar","filing":"0001209191-20-047533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919120047533/doc4.xml","form_type":"4"}},{"id":3230887,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":129580,"kind":"person","name":"Dispersyn Gerrit","position":1,"cik":"0001704417","reported_name":"Dispersyn Gerrit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2020-03-04T01:27:29.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":673,"price":2.93,"value":1971.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":14628,"source":{"system":"sec-edgar","filing":"0001209191-20-015801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919120015801/doc4.xml","form_type":"4"}},{"id":3363975,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":21579,"kind":"person","name":"Bitterman Robert J","position":1,"cik":"0001304395","reported_name":"Bitterman Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2019-11-21T00:38:56.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":300000,"price":0.1,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":320440,"source":{"system":"sec-edgar","filing":"0001209191-19-057518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304395/000120919119057518/doc4.xml","form_type":"4"}}],"next_cursor":"2019-11-21T00:38:56.000000Z,3363975"}